Pedersen IM - Search Results

1

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

Schimmer AD, Welsh K, Pinilla C, Wang Z, Krajewska M, Bonneau MJ, Pedersen IM, Kitada S, Scott FL, Bailly-Maitre B, Glinsky G, Scudiero D, Sausville E, Salvesen G, Nefzi A, Ostresh JM, Houghten RA, Reed JC. Schimmer AD, et al. Among authors: pedersen im. Cancer Cell. 2004 Jan;5(1):25-35. doi: 10.1016/s1535-6108(03)00332-5. Cancer Cell. 2004. PMID: 14749124 Free article.

2

Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.

Schimmer AD, Pedersen IM, Kitada S, Eksioglu-Demiralp E, Minden MD, Pinto R, Mah K, Andreeff M, Kim Y, Suh WS, Reed JC. Schimmer AD, et al. Among authors: pedersen im. Cancer Res. 2003 Mar 15;63(6):1242-8. Cancer Res. 2003. PMID: 12649183

3

Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.

Chu P, Deforce D, Pedersen IM, Kim Y, Kitada S, Reed JC, Kipps TJ. Chu P, et al. Among authors: pedersen im. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3854-9. doi: 10.1073/pnas.022604399. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891278 Free PMC article.

4

Dysregulation of apoptosis genes in hematopoietic malignancies.

Kitada S, Pedersen IM, Schimmer AD, Reed JC. Kitada S, et al. Among authors: pedersen im. Oncogene. 2002 May 13;21(21):3459-74. doi: 10.1038/sj.onc.1205327. Oncogene. 2002. PMID: 12032782 Review.

5

The triterpenoid CDDO induces apoptosis in refractory CLL B cells.

Pedersen IM, Kitada S, Schimmer A, Kim Y, Zapata JM, Charboneau L, Rassenti L, Andreeff M, Bennett F, Sporn MB, Liotta LD, Kipps TJ, Reed JC. Pedersen IM, et al. Blood. 2002 Oct 15;100(8):2965-72. doi: 10.1182/blood-2002-04-1174. Blood. 2002. PMID: 12351409 Free article.

6

A unified model for apical caspase activation.

Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, Salvesen GS. Boatright KM, et al. Among authors: pedersen im. Mol Cell. 2003 Feb;11(2):529-41. doi: 10.1016/s1097-2765(03)00051-0. Mol Cell. 2003. PMID: 12620239 Free article.

7

Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.

Pedersen IM, Kitada S, Leoni LM, Zapata JM, Karras JG, Tsukada N, Kipps TJ, Choi YS, Bennett F, Reed JC. Pedersen IM, et al. Blood. 2002 Sep 1;100(5):1795-801. Blood. 2002. PMID: 12176902 Free article.

8

Retraction: The triterpenoid CDDO-Imidazolide induces apoptosis and enhances fludarabine-induced apoptosis of CLL B-cells.

Pedersen IM, Zapata JM, Samuel T, Scott FL, Salvesen GS, Honda T, Gribble GW, Suh N, Sporn MB, Kipps TJ, Reed JC. Pedersen IM, et al. Blood. 2004 Aug 15;104(4):932. doi: 10.1182/blood-2003-11-3774. Epub 2004 Jan 22. Blood. 2004. PMID: 14739219 Free article. No abstract available.

9

Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.

Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, Shin DM, Ravetch JV, Bolland S, Morse HC 3rd, Rickert RC. Miletic AV, et al. Among authors: pedersen im. J Exp Med. 2010 Oct 25;207(11):2407-20. doi: 10.1084/jem.20091962. Epub 2010 Oct 18. J Exp Med. 2010. PMID: 20956547 Free PMC article.

10

Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas.

Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M. Pedersen IM, et al. EMBO Mol Med. 2009 Aug;1(5):288-95. doi: 10.1002/emmm.200900028. EMBO Mol Med. 2009. PMID: 19890474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page